Programmed Cells from Basic Neuroscience to Therapy (Research and Perspectives in Neurosciences Book 20)

★★★★★ 4.2 146 reviews

US$43.87
Price when purchased online
Free shipping Free 30-day returns

Sold and shipped by osgenglobal.com
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here.
US$43.87
Price when purchased online
Free shipping Free 30-day returns

How do you want your item?
You get 30 days free! Choose a plan at checkout.
Shipping
Arrives Jun 29
Free
Pickup
Check nearby
Delivery
Not available

Sold and shipped by osgenglobal.com
Free 30-day returns Details

Product details

Management number 232014565 Release Date 2026/06/18 List Price US$43.87 Model Number 232014565
Category

The recent advances in Programming Somatic Cell (PSC) including induced Pluripotent Stem Cells (iPS) and Induced Neuronal phenotypes (iN), has changed our experimental landscape and opened new possibilities. The advances in PSC have provided an important tool for the study of human neuronal function as well as neurodegenerative and neurodevelopmental diseases in live human neurons in a controlled environment. For example, reprogramming cells from patients with neurological diseases allows the study of molecular pathways particular to specific subtypes of neurons such as dopaminergic neurons in Parkinson’s Disease, Motor neurons for Amyolateral Sclerosis or myelin for Multiple Sclerosis. Detecting disease-specific molecular signatures in live human brain cells, opens possibilities for early intervention therapies and new diagnostic tools. Importantly, once the neurological neural phenotype is detected in vitro, the so-called “disease-in-a-dish” approach allows for the screening of drugs that can ameliorate the disease-specific phenotype. New therapeutic drugs could either act on generalized pathways in all patients or be patient-specific and used in a personalized medicine approach. However, there are a number of pressing issues that need to be addressed and resolved before PSC technology can be extensively used for clinically relevant modeling of neurological diseases. Among these issues are the variability in PSC generation methods, variability between individuals, epigenetic/genetic instability and the ability to obtain disease-relevant subtypes of neurons . Current protocols for differentiating PSC into specific subtypes of neurons are under development, but more and better protocols are needed. Understanding the molecular pathways involved in human neural differentiation will facilitate the development of methods and tools to enrich and monitor the generation of specific subtypes of neurons that would be more relevant in modeling differentneurological diseases. Read more

ASIN B00CRU4H1E
XRay Not Enabled
ISBN13 978-3642366482
Edition 2013th
Language English
File size 1.6 MB
Page Flip Enabled
Publisher Springer
Word Wise Not Enabled
Print length 255 pages
Accessibility Learn more
Screen Reader Supported
Part of series Research and Perspectives in Neurosciences
Publication date May 13, 2013
Enhanced typesetting Enabled

Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Customer ratings & reviews

4.2 out of 5
★★★★★
146 ratings | 60 reviews
How item rating is calculated
View all reviews
5 stars
78% (114)
4 stars
6% (9)
3 stars
3% (4)
2 stars
2% (3)
1 star
11% (16)
Sort by

There are currently no written reviews for this product.